Samantha McLemore - Patient Capital Management
As of Q2 2026, Samantha McLemore reported 39 long-equity positions worth $3.01B in aggregate.
It also disclosed $40.92M of call notional. Notional is the contracts’ face value, not the premium paid, so it is reported separately from the equity above — see the Options section below.
Copy-investor backtest
- Latest quarter
- +5.36%
- 1-year
- +22.50%
- 3-year
- +78.88%
- 5-year
- —
- 3-year vs S&P 500
- +5.83%
- 5-year vs S&P 500
- —
- 5-year top 5
- —
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Samantha McLemore files a new 13F — sign in or create a free account.
Reported portfolio value
This chart traces the total value of the manager’s reported 13F equity holdings quarter by quarter, so you can see how their book has grown or shrunk over time.
Quarterly rows
This table lists every reported quarter for the manager, showing the total reported value and the number of positions in each one, so you can track the full filing history at a glance.
| Period | Filed | Holdings | Total value | Delta value |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 39 | $3.01B | +$327.73M(+12.2%) |
| Q1 2026 | 2026-03-31 | 38 | $2.68B | +$91.12M(+3.5%) |
| Q4 2025 | 2025-12-31 | 40 | $2.59B | +$92.61M(+3.7%) |
| Q3 2025 | 2025-09-30 | 41 | $2.5B | +$282.39M(+12.7%) |
| Q2 2025 | 2025-06-30 | 40 | $2.22B | +$271.13M(+13.9%) |
| Q1 2025 | 2025-03-31 | 39 | $1.94B | -$222.86M(-10.3%) |
| Q4 2024 | 2024-12-31 | 43 | $2.17B | +$130.65M(+6.4%) |
| Q3 2024 | 2024-09-30 | 41 | $2.04B | +$153.94M(+8.2%) |
| Q2 2024 | 2024-06-30 | 40 | $1.88B | -$171.56M(-8.4%) |
| Q1 2024 | 2024-03-31 | 42 | $2.05B | +$170M(+9.0%) |
| Q4 2023 | 2023-12-31 | 42 | $1.88B | +$187.73M(+11.1%) |
| Q3 2023 | 2023-09-30 | 40 | $1.7B | -$98.85M(-5.5%) |
| Q2 2023 | 2023-06-30 | 43 | $1.8B | +$1.57B(+705.5%) |
| Q1 2023 | 2023-03-31 | 41 | $222.9M | +$18.44M(+9.0%) |
| Q4 2022 | 2022-12-31 | 41 | $204.46M | +$4.04M(+2.0%) |
| Q3 2022 | 2022-09-30 | 41 | $200.41M | -$24.13M(-10.7%) |
| Q2 2022 | 2022-06-30 | 40 | $224.54M | -$69.83M(-23.7%) |
| Q1 2022 | 2022-03-31 | 42 | $294.37M | -$52.58M(-15.2%) |
| Q4 2021 | 2021-12-31 | 40 | $346.95M | - |